Scopio Labs
Scopio Labs is an Israeli private VC-backed medtech startup developing AI-powered full-field digital microscopy for hematology diagnostics with dual-use potential in field medical applications.
Visit WebsiteCompany Overview
Scopio Labs develops computational microscopy technology that captures and analyzes full-field digital images of blood smears at 100x magnification, replacing traditional manual microscopy with AI-powered automated analysis. The platform counts and classifies thousands of blood cells per sample, providing standardized, reproducible hematology results.
The company's Complete Blood Morphology system has been adopted by leading hematology laboratories worldwide including Mount Sinai, PathGroup, and Synlab. The technology addresses critical laboratory challenges including rising workloads, staff shortages, and subjective variability in manual differential counts.
Dual-use relevance is credible: portable digital microscopy with AI analysis can transform field medical diagnostics for military and humanitarian operations, enabling rapid blood analysis in forward medical stations without requiring experienced hematopathologists on site.
Dual-Use Assessment
AI-powered portable digital microscopy has dual-use value for clinical laboratory hematology and military field medical point-of-care blood diagnostics.
Key Technologies
- Full-field computational microscopy at 100x magnification
- AI-powered automated cell morphology classification
- Autonomous blood smear scanning and analysis pipeline
- Remote digital pathology and teleconsultation capability
- Standardized Complete Blood Morphology reporting
Use Cases & Applications
- Clinical hematology laboratory automation
- Remote pathology consultation for underserved areas
- Military forward medical station blood diagnostics
- Point-of-care blood analysis in emergency response
- Quality standardization across distributed laboratory networks
Strategic Value to U.S.-Israel Alliance
Enhances allied medical readiness through AI-powered blood diagnostics deployable in both clinical and field settings.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.